Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

Harbin medical university affiliated tumor hospital, Haerbin

The 1st Affiliated Hospital of Bengbu Medical College, Bengbu

The Second Affiliated Hospital, Anhui Medical University, Hefei

Peking Union Medical College Hospital, Beijing

The 307th Hospital of Chinese People's Liberation Army, Beijing

Chongqing Cancer Hospital, Chongqing

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

Fujian Cancer Hospital, Fuzhou

Gansu Province Tumor Hospital, Lanzhou

The First Affiliated Hospital of Sun Yat-sen university, Guangzhou

The Sixth Affiliated Hospital of Sun Yat-sen university, Guangzhou

Guangxi medical university affiliated tumor hospital, Nanning

The Second xiangya Hospital of Central South University, Changsha

The First People's Hospital of Lianyungang, Lianyungang

Jiangsu Cancer Hospital, Nanjing

Jiangsu Province Hospital, Nanjing

Nantong Cancer Hospital, Nantong

Jiangxi Cancer Hospital, Nanchang

The First Affiliated Hospital of Nanchang University, Nanchang

Jilin Cancer Hospital, Changchun

Liaoning Province Tumor Hospital, Shenyang

Qilu Hospital，Shandong University, Jinan

Cancer Hospital of Fudan University, Shanghai

Shanxi Cancer Hospital, Xian

Tangdu Hospital of The fourth Military Medical University, Xian

The First Affiliated Hospital of Xian Jiaotong University, Xian

Tianjin Medical University Cancer Hospital, Tianjin

The First Affiliated Hospital of Zhejiang University, Hangzhou